ELAVL2 and central nervous system cancer: To further substantiate the prognostic role of ELAVL2 in glioma, we analyzed the protein expression level of ELAVL2 in 182 glioma patients with follow-up information across four TMA sets (TMA1573, 2248, 2249, 2758) using an anti-ELAVL2 antibody.